AGP Picks
View all

Healthy Living Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.

Press releases published on June 2, 2026

Thumbay International Pathway Celebrates a Decade and 90 New Doctors at the Convocation
IVF.com Repriced at $1.2M: The Digital Front Door to the Fertility Industry Is Now More Accessible
Throat Soothing Hard Candy Market to Reach $6.42 Billion by 2030 with 6% CAGR
Smoking Condensate Filtration Systems Market Outlook 2030: Market Size, CAGR, Trends And Forecast Analysis
Spare Parts Kitting For Aseptic Fillers Market to Reach USD $1.9 Billion by 2030 at 9.4% CAGR
Thermoformed Medical Packaging Market To Witness Strong Growth Trajectory Through 2030 At 6.2% CAGR
LinkShadow is positioned in the Visionaries Quadrant in the 2026 Gartner® Magic Quadrant™ for NDR
CYduct Diagnostics, Inc. Proudly Supports CaringKind’s Inaugural Hope Blooms Event in Connecticut
Alercell Appoints Paul A. Dreschnack, MD, Harvard Surgeon and Four-Time Nobel Peace Prize Nominee, to Advisory Board
Uplizd Offers Custom Agentic AI Infrastructure to Revolutionize Biologic Formulation Development in Pharmaceutical R&D
Global MR Community Convened in Cape Town for 2026 Annual Meeting as ISMRM & ISMRT Passed the Gavel to New Presidents
TheAnswerPage.com Launches 6-hour CME/CE Program to Support Clinicians, Health Systems & State Medical Cannabis Programs
CV6 Therapeutics Appoints Dr. Chris Takimoto to Board as CV6-168 Advances Through Phase 1a
DBV Technologies Announces First Participant Screened in THRIVE Phase 2 Study of the VIASKIN® Peanut Patch in Infants ages 6 through 12 Months with Peanut Allergy
DBV Technologies annonce le screening du premier participant de l’étude clinique de phase 2 THRIVE pour le patch VIASKIN® Peanut chez les nourrissons âgés de 6 à 12 mois allergiques à l’arachide
OTC Scar Treatment Market Set to Reach US$ 17.4 Bn by 2033 at 6.5% CAGR | Persistence Market Research
Tim Brown Expands Executive Crisis Advisory Access Following Launch of Crisis Response System for Leaders
Business Reporter: Bridging the instruction gap
Zenas BioPharma Announces Data from the Registrational Phase 3 INDIGO Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD), Simultaneously Presented at the EULAR 2026 Congress and Published in the New England Journal of Medicine
3D Printed Clear Dental Aligners Market to Witness Steady Expansion at 8.2% CAGR Through 2032

Share this page:

Sign up for:

Healthy Living Europe

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.